The Biden administration will issue a notice of proposed rulemaking to forbid all goods subject to major trade actions, including Section 301 tariffs, from de minimis entry, the White House announced. It will also issue a notice of proposed rulemaking to require information submissions for de minimis packages, including the 10-digit HTS code and the person receiving the goods.
CBP CROSS Rulings
CBP issues binding advance rulings in connection with the importation of merchandise into the United States. They issue the rulings to give the trade community transparency of how CBP will treat a prospective import or carrier transaction. Common rulings include the tariff classification, country of origin, or free trade agreement applicability of merchandise, among other things. These rulings are available in CBP's Customs Rulings Online Search System (CROSS) database.
CBP has released its Sept. 11 Customs Bulletin (Vol. 58, No. 36), which includes the following ruling actions:
Republican members of the House Energy and Commerce's Health Subcommittee criticized the FDA's Center for Tobacco Products for giving its blessing to so few vaping delivery systems and liquids put in electronic cigarettes, saying that the vast black market of vaping products is benefiting China, and that having so few legitimate products available makes it more dangerous for smokers who are wanting to switch from cigarettes to vaping, which is less harmful to their health.
The following lawsuits were filed at the Court of International Trade during the weeks of Aug. 19-25, Aug. 26 - Sept. 1, Sept. 2-8:
CBP issued the following releases on commercial trade and related matters:
CBP recently issued a fact sheet on country of origin marking requirements applicable to imported repackaged prescription medication, the agency said in a CSMS message. All repackaged medications sold to retail customers will be required to be marked with the country of origin, CBP said. In the fact sheet, the agency referenced its recent ruling on country of origin marking for prescription medications, which found a retail pharmacy still has to include country of origin on drugs it repackages before selling to the ultimate consumer (see 2408140037).
International Trade Today is providing readers with the top stories from last week in case they were missed. All articles can be found by searching on the titles or by clicking on the hyperlinked reference number.
House Ways and Means Trade Subcommittee Chairman Adrian Smith, R-Neb., said members of Congress have a wide range of views "of what the reaction should be" to compliance weaknesses in de minimis shipments. "But I think we need to continue the conversation and look for solutions that can generate the results we need," he said. Smith said he thinks Congress can pass a de minimis bill this year.
CBP issued the following releases on commercial trade and related matters:
The Court of International Trade on Sept. 9 rejected importer Katana Racing's renewed motion to dismiss the govenrment's action against it seeking over $5.7 million in unpaid duties on passenger vehicle and light truck tires from China, after the U.S. Court of Appeals for the Federal Circuit reversed the trade court's previous dismissal of the case. In her first opinion since being confirmed to the court, Judge Lisa Wang said the U.S. didn't fail to properly identify the "person" liable for the violation, exhaust administrative remedies or bring the case on time (U.S. v. Katana Racing, CIT # 19-00125).